Sapience Therapeutics Announces First Patient Dosed with ST101 in Phase 1/2 Study in Patients with Advanced Unresectable and Metastatic Solid Tumors -…
stemadminStem Cell ResearchNo comments

HARRISON, NY / ACCESSWIRE / August 12, 2020 / Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address difficult-to-treat oncology indications, today announced dose administration for the first patient in a Phase 1/2, open-label, dose escalation and expansion study of single agent ST101, a peptide therapy being evaluated for the treatment of adults with unresectable and metastatic solid tumors who are not eligible for other therapies or have progressed on prior therapies. "The initiation of this study represents a significant milestone for Sapience, as it marks the first program from our portfolio of peptide therapies to enter the clinic," said Alice Bexon, M.D., Chief Medical Officer of Sapience Therapeutics. "The ST101 program highlights Sapience's therapeutic approach of using peptides to target intracellular protein-protein interactions, which are often referred to as 'Undruggable Targets'.

Read more
Study: Early training of cell development and network improves response – News-Medical.Net
stemadminStem Cell ResearchNo comments

When it comes to training neural circuits for tissue engineering or biomedical applications, a new study suggests a key parameter: Train them young. Techniques for training engineered neural circuits usually involve training them after the cells have fully matured. Using light-sensitive neurons derived from mouse stem cells, researchers at the University of Illinois, Urbana-Champaign found that training them throughout early cell development and network formation led to lasting improvements in the connections, responsivity and gene expression of the resulting neural network

Read more
US government considers ethics of aborted tissue research – Angelus News
stemadminStem Cell ResearchNo comments

A new federal ethics advisory board for fetal tissue research has convened to consider future federally-funded research proposals that involve tissue from aborted babies. The Human Fetal Tissue Research Ethics Advisory Board of the National Institutes of Health (NIH) met for the first time on July 31, to advise the Health Secretary on the ethics of research proposals involving fetal tissue of aborted babies

Read more
BCLI: Phase 3 ALS Data Expected by the End of November 2020 – Zacks Small Cap Research
stemadminStem Cell ResearchNo comments

By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Topline Data from Phase 3 ALS Trial Before End of November 2020 BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) is currently conducting a Phase 3 clinical trial of NurOwn in patients with amyotrophic lateral sclerosis (ALS) (NCT03280056). A total of 200 patients were randomized 1:1 to receive NurOwn or placebo in the randomized, double blind, placebo controlled, multi-dose trial.

Read more
Stem Cell Media Market with Competitive Analysis, New Business Developments and Top Companies: Thermo Fisher, STEMCELL Technologies – Owned
stemadminStem Cell ResearchNo comments

Stem Cell Media Market Overview 2020 2025 This has brought along several changes in This report also covers the impact of COVID-19 on the global market. The risingtechnology in Stem Cell Media Marketis also depicted in thisresearchreport. Factors that are boosting the growth of the market, and giving a positive push to thrive in the global market is explained in detail

Read more
In Depth Analysis and Survey of COVID-19 Pandemic Impact on Global Umbilical Cord Blood (UCB) Stem Cell Market Report PDF 2020 Key Players Advanced…
stemadminStem Cell ResearchNo comments

Report is a detailed study of the Umbilical Cord Blood (UCB) Stem Cell market, which covers all the essential information required by a new market entrant as well as the existing players to gain a deeper understanding of the market.The primary objective of this research report named Umbilical Cord Blood (UCB) Stem Cell market is to help making reliable strategic decisions regarding the opportunities in Umbilical Cord Blood (UCB) Stem Cell market. It offers business accounts, industry investors, and industry segments with consequential insights enhancing decision making ability.nicolas.shaw@cognitivemarketresearch.com or call us on +1-312-376-8303.

Read more
Plant Stem Cell Market 2020 Share Growing Rapidly With Latest Trends, Development, Revenue, Demand And Forecast To 2029 – Owned
stemadminStem Cell ResearchNo comments

The research study on Global Plant Stem Cell market 2019 presents an extensive analysis of current Plant Stem Cell market size, drivers, trends, opportunities, challenges, as well as key Plant Stem Cell market segments. Further, it explains various definitions and classification of the Plant Stem Cell industry, applications, and chain structure.In continuation of this data, the Plant Stem Cell report covers various marketing strategies followed by key players and distributors

Read more
New Research Sheds Light on the Temporary Loss of Smell Stemming from COVID-19 – BioSpace
stemadminStem Cell ResearchNo comments

According to a study published in the journal Science Advances on July 24, an international team of researchers led by neuroscientists at Harvard Medical School has uncovered which olfactory cell types are most vulnerable to infection by SARS-CoV-2, which causes COVID-19. A loss of the sense of smell has been deemed an underlying symptom of COVID-19 in some patients. However, researchers have found that sensory neurons that detect and transmit the sense of smell to the brain are not among vulnerable cell types.

Read more

Theme: Illdy.